Cargando…

Anti-CD20 therapies for multiple sclerosis: current status and future perspectives

Multiple sclerosis (MS) is a chronic inflammatory, demyelinating and neurodegenerative disease affecting the central nervous system (CNS), often characterized by the accumulation of irreversible clinical disability over time. During last years, there has been a dramatic evolution in several key conc...

Descripción completa

Detalles Bibliográficos
Autores principales:	Margoni, Monica, Preziosa, Paolo, Filippi, Massimo, Rocca, Maria A.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Springer Berlin Heidelberg 2021
Materias:	Review
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8356891/ https://www.ncbi.nlm.nih.gov/pubmed/34382120 http://dx.doi.org/10.1007/s00415-021-10744-x

Ejemplares similares

Depressive symptoms, anxiety and cognitive impairment: emerging evidence in multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2023)

Present and future of the diagnostic work-up of multiple sclerosis: the imaging perspective
por: Filippi, Massimo, et al.
Publicado: (2022)

The insula modulates the effects of aerobic training on cardiovascular function and ambulation in multiple sclerosis
por: Albergoni, Matteo, et al.
Publicado: (2022)

COVID-19 in cladribine-treated relapsing-remitting multiple sclerosis patients: a monocentric experience
por: Preziosa, Paolo, et al.
Publicado: (2020)

Task- and resting-state fMRI studies in multiple sclerosis: From regions to systems and time-varying analysis. Current status and future perspective
por: Rocca, Maria A., et al.
Publicado: (2022)

Slowly Expanding Lesions Predict 9-Year Multiple Sclerosis Disease Progression
por: Preziosa, Paolo, et al.
Publicado: (2022)

Exploring the Association of HLA Genetic Risk Burden on Thalamic and Hippocampal Atrophy in Multiple Sclerosis Patients
por: Santoro, Silvia, et al.
Publicado: (2022)

Current application of neurofilaments in amyotrophic lateral sclerosis and future perspectives
por: Falzone, Yuri Matteo, et al.
Publicado: (2021)

Clinical Perspectives on the Molecular and Pharmacological Attributes of Anti-CD20 Therapies for Multiple Sclerosis
por: Bar-Or, Amit, et al.
Publicado: (2021)

Early use of high-efficacy disease‑modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Correction to: Early use of high-efficacy disease-modifying therapies makes the difference in people with multiple sclerosis: an expert opinion
por: Filippi, Massimo, et al.
Publicado: (2022)

Anti-CD20 Agents for Multiple Sclerosis: Spotlight on Ocrelizumab and Ofatumumab
por: Florou, Despoina, et al.
Publicado: (2020)

Anti-CD20 B Cell Treatment for Relapsing Multiple Sclerosis
por: Roach, Charles A., et al.
Publicado: (2021)

Learning multiple sclerosis immunopathogenesis from anti-CD20 therapy
por: Heming, Michael, et al.
Publicado: (2023)

Anti-CD20 therapies in multiple sclerosis: From pathology to the clinic
por: de Sèze, Jérôme, et al.
Publicado: (2023)

Cognition in multiple sclerosis: State of the field and priorities for the future
por: Sumowski, James F., et al.
Publicado: (2018)

Editorial: “Inside-Out” vs “Outside-In” Paradigms in Multiple Sclerosis Etiopathogenesis
por: Luchicchi, Antonio, et al.
Publicado: (2021)

Mapping brain structure and function in professional fencers: A model to study training effects on central nervous system plasticity
por: Cordani, Claudio, et al.
Publicado: (2022)

Current Status and Future Opportunities in Modeling Clinical Characteristics of Multiple Sclerosis
por: Liu, Joshua, et al.
Publicado: (2022)

The Role of T1-Weighted Derived Measures of Neurodegeneration for Assessing Disability Progression in Multiple Sclerosis
por: Rocca, Maria A., et al.
Publicado: (2017)

Assessment of lesions on magnetic resonance imaging in multiple sclerosis: practical guidelines
por: Filippi, Massimo, et al.
Publicado: (2019)

A Personalized Approach in Progressive Multiple Sclerosis: The Current Status of Disease Modifying Therapies (DMTs) and Future Perspectives
por: D’Amico, Emanuele, et al.
Publicado: (2016)

Chemopreventive Herbal Anti-Oxidants: Current Status and Future Perspectives
por: Patel, Rachana, et al.
Publicado: (2007)

Anti-CD20 therapy depletes activated myelin-specific CD8(+) T cells in multiple sclerosis
por: Sabatino, Joseph J., et al.
Publicado: (2019)

COVID-19 in 7 multiple sclerosis patients in treatment with ANTI-CD20 therapies
por: Meca-Lallana, Virginia, et al.
Publicado: (2020)

Cortical axonal loss is associated with both gray matter demyelination and white matter tract pathology in progressive multiple sclerosis: Evidence from a combined MRI-histopathology study
por: Kiljan, Svenja, et al.
Publicado: (2020)

Current and Future Therapies for Multiple Sclerosis
por: Minagar, Alireza
Publicado: (2013)

Current and Future Biomarkers in Multiple Sclerosis
por: Yang, Jennifer, et al.
Publicado: (2022)

Early red nucleus atrophy in relapse‐onset multiple sclerosis
por: Margoni, Monica, et al.
Publicado: (2020)

Pharmacogenetic Biomarkers to Predict Treatment Response in Multiple Sclerosis: Current and Future Perspectives
por: Coyle, Patricia K.
Publicado: (2017)

COVID-19 in teriflunomide-treated patients with multiple sclerosis
por: Maghzi, Amir Hadi, et al.
Publicado: (2020)

Current status and future directions of amyotrophic lateral sclerosis research in Africa: a perspective
por: Aderinto, Nicholas, et al.
Publicado: (2023)

Systematic literature review of immunoglobulin trends for anti-CD20 monoclonal antibodies in multiple sclerosis
por: Saidha, Shiv, et al.
Publicado: (2023)

Severe Neuroinvasive West Nile Virus in Association With Anti-CD20 Monotherapy for Multiple Sclerosis
por: Thebault, Simon, et al.
Publicado: (2023)

Monoclonal antibodies in the treatment of multiple myeloma: current status and future perspectives
por: Lonial, S, et al.
Publicado: (2016)

Theranostic Implications of Nanotechnology in Multiple Sclerosis: A Future Perspective
por: Singh, Ajay Vikram, et al.
Publicado: (2012)

Diagnosis and treatment of multiple sclerosis in pediatric and adolescent patients: current status and future therapies
por: Yeh, E Ann
Publicado: (2010)

Cerebellar pathology in multiple sclerosis and experimental autoimmune encephalomyelitis: current status and future directions
por: Maxwell, Dain L., et al.
Publicado: (2023)

Gut Microbiota in Multiple Sclerosis and Experimental Autoimmune Encephalomyelitis: Current Applications and Future Perspectives
por: Chu, Fengna, et al.
Publicado: (2018)

Intrathecal CD8(+)CD20(+) T Cells in Primary Progressive Multiple Sclerosis
por: von Essen, Marina Rode, et al.
Publicado: (2023)

Cannot write session to /tmp/vufind_sessions/sess_rqgvh52pr70cmr0v4cv92ejkoc